BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 31348611)

  • 1. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
    D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
    Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
    Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
    Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological Diagnosis of Bilateral Breast Implant-Associated Lymphoma of the ALK-Negative Anaplastic Large-Cell Type. Clinical Implications of Peri-Implant Breast Seroma Cytological Reporting.
    Granados R; Lumbreras EM; Delgado M; Aramburu JA; Tardío JC
    Diagn Cytopathol; 2016 Jul; 44(7):623-7. PubMed ID: 27079579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.
    Wu D; Allen CT; Fromm JR
    Cytometry B Clin Cytom; 2015 Jan; 88(1):58-63. PubMed ID: 25044944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    Eur J Surg Oncol; 2021 Feb; 47(2):199-210. PubMed ID: 33358076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
    Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
    Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Implant-associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms.
    Sharma B; Jurgensen-Rauch A; Pace E; Attygalle AD; Sharma R; Bommier C; Wotherspoon AC; Sharma S; Iyengar S; El-Sharkawi D
    Radiographics; 2020; 40(3):609-628. PubMed ID: 32302264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
    Kadin ME; Adams WP; Inghirami G; Di Napoli A
    Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Oishi N; Miranda RN; Feldman AL
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
    Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
    Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
    Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
    JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
    Fitzal F; Turner SD; Kenner L
    Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
    Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity.
    Xu J; Wei S
    Arch Pathol Lab Med; 2014 Jun; 138(6):842-6. PubMed ID: 24878027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
    Turner SD; Inghirami G; Miranda RN; Kadin ME
    Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
    Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
    Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.